Some Mendelian diseases are associated with increased cancer risk, including hemophilia and other diverse developmental, neurological, and metabolic disorders. We hypothesized that the germline mutations that cause Mendelian disease, and predispose those patients to cancer, have similarity to the somatic alterations that drive cancer development in most patients.